US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ecopetrol SA

8.29

-0.1052-1.25%

Volume:1.40M

Turnover:11.73M

Market Cap:17.05B

PE:5.09

High:8.44

Open:8.34

Low:8.29

Close:8.40

Loading ...

Overview Company News Filings

Bristol Myers Squibb Receives Positive CHMP Opinion for the Subcutaneous Formulation of Opdivo® (nivolumab) Across Multiple Solid Tumor Indications

Market Chatter: EU Readies 'Robust' Response to New US Import Tariffs, EC Spokesman Says

MT Newswires Live

Merck (NYSE:MRK) Gains EC Approval For CAPVAXIVE® Amid Recent 7% Share Price Dip

Simply Wall St.

How to link your Aadhaar Card to your Voter ID: A step-by-step guide

European Commission (EC) Approves Merck’s CAPVAXIVE® (Pneumococcal 21-valent Conjugate Vaccine) for Prevention of Invasive Pneumococcal Disease and Pneumococcal Pneumonia in Adults

ECP Asset Management and EC Pohl & Co Cease Substantial Holding in Nanosonics Limited

Shell Invests in Gato do Mato to Drive Brazil's Pre-Salt Growth

Is Bristol-Myers Squibb (BMY) Among the Cheap Stocks to Buy According to Billionaires?

Shell's Brazil Subsidiary Joins Consortium Developing Gato do Mato Offshore Project

MT Newswires Live

Press Release: InflaRx Reports Full Year 2024 Results and Highlights Key Achievements and Expected Milestones

Rhythm Pharmaceuticals Announces Orphan Drug Designation Granted to Setmelanotide for Treatment of Hypothalamic Obesity in Japan

EC World REIT Announces New Property Management Agreements

EC World Reit appoints new property managers, port operator

Bristol-Myers Squibb (NYSE:BMY) Gets EC Nod For Breyanzi In NHL Treatment

Simply Wall St.

Bristol Myers announces EC approval of Breyanzi

Bristol Myers Squibb Receives Approval from the European Commission to Expand Use of CAR T Cell Therapy Breyanzi for Relapsed or Refractory Follicular Lymphoma

Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2024 and Provides a Business Update

Rxulti® (brexpiprazole) approved in the European Union for the treatment of schizophrenia in adolescents aged 13 years and older

Geron Announces European Commission Approval of RYTELO® (imetelstat), a First-in-Class Telomerase Inhibitor, for the Treatment of Adults With Transfusion-Dependent Anemia Due to Lower-Risk MDS

Petrobras' Board Approves $283 Million Settlement Agreement

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/EC/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"EC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EC\",,,,,undefined,":{"symbol":"EC","market":"US","secType":"STK","nameCN":"Ecopetrol SA","latestPrice":8.2948,"timestamp":1754067854987,"preClose":8.4,"halted":0,"volume":1402238,"delay":0,"floatShares":233420503,"shares":2055834734,"eps":1.629527,"marketStatus":"Trading","change":-0.1052,"latestTime":"08-01 13:04:24 EDT","open":8.34,"high":8.435,"low":8.2948,"amount":11727770.356942,"amplitude":0.01669,"askPrice":8.3,"askSize":379,"bidPrice":8.29,"bidSize":600,"shortable":3,"etf":0,"ttmEps":1.629527,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1754078400000},"marketStatusCode":2,"adr":1,"adrRate":20,"listingDate":1221710400000,"exchange":"NYSE","adjPreClose":8.4,"dividendRate":0.200125,"preHourTrading":{"tag":"盘前","latestPrice":8.36,"preClose":8.4,"latestTime":"09:28 EDT","volume":1374,"amount":11480.216550000001,"timestamp":1754054888869},"postHourTrading":{"tag":"盘后","latestPrice":8.4,"preClose":8.4,"latestTime":"19:37 EDT","volume":1491,"amount":12528.46,"timestamp":1754005075322},"volumeRatio":1.316123,"impliedVol":0.4758,"impliedVolPercentile":0.472},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EC\",,,,,undefined,":{"symbol":"EC","floatShares":233420503,"roa":"7.63%","roe":"19.11%","lyrEps":1.647439,"volumeRatio":1.316123,"shares":2055834734,"dividePrice":1.66,"high":8.435,"amplitude":0.01669,"preClose":8.4,"low":8.2948,"week52Low":7.21,"pbRate":"0.91","psRate":"0.53","week52High":11.045,"institutionHeld":0,"latestPrice":8.2948,"committee":0.225741,"eps":1.629527,"divideRate":0.200125,"volume":1402238,"delay":0,"ttmEps":1.629527,"open":8.34,"prevYearClose":7.92,"prevWeekClose":8.58,"prevMonthClose":8.4,"prevQuarterClose":8.85,"fiveDayClose":8.58,"twentyDayClose":9.17,"sixtyDayClose":7.88,"earningDate":1754928000000,"earningTime":"盘后"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"EC\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2522257316","title":"Bristol Myers Squibb Receives Positive CHMP Opinion for the Subcutaneous Formulation of Opdivo® (nivolumab) Across Multiple Solid Tumor Indications","url":"https://stock-news.laohu8.com/highlight/detail?id=2522257316","media":"Business Wire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522257316?lang=en_us&edition=fundamental","pubTime":"2025-03-28 20:00","pubTimestamp":1743163200,"startTime":"0","endTime":"0","summary":"Recommendation is based primarily on results from the Phase 3 CheckMate -67T trial which demonstrated noninferiority in the co-primary endpoints of Cavgd28 and Cminss and consistent efficacy in the secondary endpoint of overall response rate for the subcutaneous formulation of Opdivo vs. its intravenous formulation. A decision on the EU Opdivo extension of marketing authorization is expected by June 2, 2025. \"The positive CHMP opinion is an important step forward in the evolution of immuno-oncology and in the potential of subcutaneous nivolumab to help transform the lives of people living with cancer,\" said Dana Walker, M.D., M.S.C.E., Opdivo global program lead, Bristol Myers Squibb. \"We look forward to bringing the same high-quality care that transformed cancer treatment with an administration method that has the potential to improve the patient experience and efficiency of healthcare systems in Europe.\"","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bristol-myers-squibb-receives-positive-120000105.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1291159041.SGD","LU1670711123.USD","BK4532","LU0237698245.USD","IE0002141913.USD","LU1032466523.USD","LU1093756325.SGD","LU2133065610.SGD","LU0321505439.SGD","VOD","IE0009355771.USD","CRT","LU1093756168.USD","BK4007","LU1261432733.SGD","LU1670710588.SGD","LU2242652126.USD","BK4528","LU0456855351.SGD","RCC","LU1670710661.SGD","TEN","CHMP","LU1868836914.USD","BK4500","LU0096364046.USD","EEA","LU0306807586.USD","ORR","BMY","LU0868494617.USD","LU1074936037.SGD","EC","LU0882574055.USD","BK4156","BK4559","MYE","LU1718418525.SGD","LU1670711040.USD","IE00BJJMRZ35.SGD","ALK","BK4585","HSCT","BK4008","BK4534","LU1323610961.USD","IE00BFTCPJ56.SGD","LU0061475181.USD","UK"],"gpt_icon":0},{"id":"2522301593","title":"Market Chatter: EU Readies 'Robust' Response to New US Import Tariffs, EC Spokesman Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2522301593","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522301593?lang=en_us&edition=fundamental","pubTime":"2025-03-27 21:48","pubTimestamp":1743083338,"startTime":"0","endTime":"0","summary":"The European Union is readying its response to US President Donald Trump's newly announced tariffs on imported vehicles, Reuters reported Thursday, citing European Commission spokesperson Olof Gill.Gill said the European Union's response to the tariffs will be \"timely,\" as well as \"robust\" and \"well calibrated,\" according to Reuters.The spokesperson didn't immediately respond to a request for comment from MT Newswires.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EC","BK4201","BK4156"],"gpt_icon":0},{"id":"2522533475","title":"Merck (NYSE:MRK) Gains EC Approval For CAPVAXIVE® Amid Recent 7% Share Price Dip","url":"https://stock-news.laohu8.com/highlight/detail?id=2522533475","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522533475?lang=en_us&edition=fundamental","pubTime":"2025-03-27 01:32","pubTimestamp":1743010330,"startTime":"0","endTime":"0","summary":"Merck has recently achieved a significant milestone with the European Commission's approval of its pneumococcal vaccine CAPVAXIVE, boosting its portfolio in the vaccines market. Despite this positive development, the company's share price encountered a 1.82% decline over the last month, a period marked by substantial turmoil across global markets. Influenced by concerns related to potential U.S. tariffs and the broader selloff in the technology sector, many investors were cautious. While the market has seen a modest recovery, Merck's performance seemed to contrast with broader market trends, like the tech sector selloff impacting investor sentiment.View our complete analysis and fair value estimate and you decide.NYSE:MRK Revenue & Expenses Breakdown as at Mar 2025. Despite these successes, Merck's performance over the past year saw challenges. The decision to pause GARDASIL shipments to China due to inventory issues marked short-term disruptions. Similarly, regulatory hurdles and stif","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/merck-nyse-mrk-gains-ec-173210476.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4550","LU0265550359.USD","LU1035773651.USD","LU1941712348.USD","IE00BLSP4452.SGD","LU1116320901.HKD","LU2023250504.SGD","LU2361045086.USD","SG9999013999.USD","SG9999014542.SGD","LU0208291251.USD","EC","LU0203347892.USD","LU1917777945.USD","BK4585","LU0106261372.USD","LU2112291526.USD","LU2361044865.SGD","LU2361044949.HKD","LU0320765489.SGD","LU0289739699.SGD","LU2089984988.USD","IE00B4R5TH58.HKD","BK4007","SG9999014559.SGD","LU2106854487.HKD","BK4534","SG9999001176.SGD","IE00BSNM7G36.USD","NYSE","LU1023059063.AUD","SG9999001176.USD","LU1699723380.USD","LU1974910355.USD","LU0238689110.USD","LU2023250843.SGD","LU1093756325.SGD","SG9999015358.SGD","LU1989772840.SGD","LU1934455863.HKD","IE0009355771.USD","LU1989772923.USD","LU1941712264.USD","BK4559","MRK","LU0965509283.SGD","LU1983299246.USD","IE000M9KFDE8.USD","LU1066051811.HKD","LU1571399168.USD"],"gpt_icon":0},{"id":"2522808218","title":"How to link your Aadhaar Card to your Voter ID: A step-by-step guide","url":"https://stock-news.laohu8.com/highlight/detail?id=2522808218","media":"ByHT News Desk","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522808218?lang=en_us&edition=fundamental","pubTime":"2025-03-26 18:59","pubTimestamp":1742986740,"startTime":"0","endTime":"0","summary":"This matter was discussed at a high-level meeting last week between senior officers of the Election Commission  and representatives from the Home Ministry, Law Ministry, IT Ministry, and UIDAI, and is likely to be part of the amended Form 6B, according to an Indian Express report. As a result, the following is all about how to link your Aadhaar to your Voter ID. Also Read: India to scrap ‘Google Tax’ from April 1: What is it?","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.hindustantimes.com/india-news/how-to-link-your-aadhaar-card-to-your-voter-id-a-step-by-step-guide-101742980576052.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"hindustan_highlight","symbols":["BK4201","EC"],"gpt_icon":0},{"id":"2522282027","title":"European Commission (EC) Approves Merck’s CAPVAXIVE® (Pneumococcal 21-valent Conjugate Vaccine) for Prevention of Invasive Pneumococcal Disease and Pneumococcal Pneumonia in Adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2522282027","media":"Business Wire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522282027?lang=en_us&edition=fundamental","pubTime":"2025-03-26 18:45","pubTimestamp":1742985900,"startTime":"0","endTime":"0","summary":"EC decision marks the fourth approval for CAPVAXIVE for pneumococcal vaccination in adults. This decision authorizes the marketing of CAPVAXIVE in all 27 European Union  member states, as well as Iceland, Liechtenstein and Norway. The timing for availability of CAPVAXIVE in individual countries will depend on multiple factors, including the completion of reimbursement procedures. CAPVAXIVE was approved in the U.S. in June 2024, in Canada in July 2024, and in Australia in January 2025.\"Pneumococcal disease continues to pose a significant risk for adults in Europe, among adults who are 65 or older, and also among younger adults who are immunocompromised or have chronic medical conditions,\" said Dr. Lina Pérez Breva, Vaccine Research, Fisabio - Public Health, Valencia, Spain. \"Based on data from the Phase 3 STRIDE clinical program, CAPVAXIVE offers coverage against the serotypes responsible for the majority of invasive disease cases in adults, making this approval in the EU an important s","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/european-commission-ec-approves-merck-104500234.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0234572021.USD","BK4201","LU0265550359.USD","MRK","LU1116320901.HKD","LU0106261372.USD","IE00BLSP4452.SGD","BK4533","LU1989772923.USD","IE0002141913.USD","LU0265550946.USD","IE0009355771.USD","SG9999014575.USD","LU0006306889.USD","IE00BJT1NW94.SGD","LU1093756325.SGD","BK4534","LU1585245621.USD","LU1057294990.SGD","LU1989771016.USD","SG9999001440.SGD","BK4007","IE000M9KFDE8.USD","LU0058720904.USD","LU1291159041.SGD","LU1116320737.USD","SG9999001176.SGD","IE00BSNM7G36.USD","EC","SG9999015358.SGD","SG9999015341.SGD","LU1061106388.HKD","SG9999001176.USD","LU1941712348.USD","LU1934455194.USD","LU1037948541.HKD","BK4156","LU1035773651.USD","LU1069347547.HKD","LU2324357040.USD","IE00BBT3K403.USD","IE00BLSP4239.USD","IE00BJJMRZ35.SGD","SG9999013999.USD","LU2112291526.USD","LU1974910355.USD","LU1989772840.SGD","LU0211331839.USD","LU0965509101.SGD"],"gpt_icon":0},{"id":"2522888186","title":"ECP Asset Management and EC Pohl & Co Cease Substantial Holding in Nanosonics Limited","url":"https://stock-news.laohu8.com/highlight/detail?id=2522888186","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522888186?lang=en_us&edition=fundamental","pubTime":"2025-03-26 02:38","pubTimestamp":1742927881,"startTime":"0","endTime":"0","summary":"Nanosonics Limited ( ($AU:NAN) ) has shared an announcement. Nanosonics Limited announced that ECP Asset Management Pty Ltd and EC Pohl & Co Pty Lt...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ecp-asset-management-and-ec-pohl-co-cease-substantial-holding-in-nanosonics-limited?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ecp-asset-management-and-ec-pohl-co-cease-substantial-holding-in-nanosonics-limited?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4201","EC"],"gpt_icon":0},{"id":"2521724213","title":"Shell Invests in Gato do Mato to Drive Brazil's Pre-Salt Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2521724213","media":"Zacks","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521724213?lang=en_us&edition=fundamental","pubTime":"2025-03-24 18:26","pubTimestamp":1742811960,"startTime":"0","endTime":"0","summary":"Shell plc’s SHEL subsidiary, Shell Brasil Petróleo Ltda. , has taken an important step in the development of Brazil's energy resources by approving the Final Investment Decision  for the Gato do Mato project. This deep-water venture, located in the pre-salt layer of the Santos Basin off the coast of Brazil, represents a breakthrough for both SHEL and the global energy market. The project is poised to significantly contribute to Brazil’s oil and gas industry, strengthening SHEL’s position as the largest foreign producer in the country.As a deep-water gas-condensate discovery, Gato do Mato promises to be a cornerstone for Brazil’s growing oil production. The project is designed to produce up to 120,000 barrels of oil per day, further contributing to the stability and expansion of Brazil's oil and gas sector.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/shell-invests-gato-mato-drive-102600796.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0300736492.USD","EC","BK4585","LU2129689431.USD","TTE","LU0098860793.USD","BK4179","LU2237443895.HKD","LU2129689514.USD","LU1162221912.USD","LU0300736062.USD","LU2237443465.HKD","LU2237443382.USD","LU2129689605.HKD","LU2237443549.SGD","LU2237443622.USD","LU0320765646.SGD","BK4588","LU2237443978.SGD","SHEL","LU2236285917.USD","LU0278409577.USD","BK4201","BK4561","AROC"],"gpt_icon":0},{"id":"2521244858","title":"Is Bristol-Myers Squibb (BMY) Among the Cheap Stocks to Buy According to Billionaires?","url":"https://stock-news.laohu8.com/highlight/detail?id=2521244858","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521244858?lang=en_us&edition=fundamental","pubTime":"2025-03-23 04:04","pubTimestamp":1742673883,"startTime":"0","endTime":"0","summary":"We recently published a list of the 15 Best and Cheap Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Bristol-Myers Squibb Company  stands against the other cheap stocks held by billionaires.The S&P 500 index is trading around its all-time high, and the short-term market indicators aren’t much evident with the latest U.S. tariff policy under implementation.Billionaire investor and CEO of Berkshire Hathaway Warren Buffett sold a record $134 billion worth of stock in 2024. Buffett’s move is considered a benchmark among investors to assess the market. Historically, when Buffett’s firm becomes a net seller, it’s often followed by below-average market performance. Many believe that this could be a signal of stock market underperformance in 2025. Cheap stocks held by billionaire investors can be a great option considering the current uncertainty in the market.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bristol-myers-squibb-bmy-among-200443552.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BJJMRZ35.SGD","LU1670711040.USD","LU2133065610.SGD","LU0096364046.USD","LU0321505868.SGD","IE00B3S45H60.SGD","BK4532","BK4550","LU0130102774.USD","IE00BFXG1179.USD","LU1261432733.SGD","BK4533","IE00B2B36J28.USD","LU2360032135.SGD","LU1571399168.USD","LU0061475181.USD","LU0971096721.USD","IE00BSNM7G36.USD","LU1291159041.SGD","LU1363072403.SGD","EC","LU0742534661.SGD","LU0456855351.SGD","LU1868836591.USD","LU0234570918.USD","LU0251131958.USD","LU1093756168.USD","LU1074936037.SGD","LU1868836757.USD","LU0648001328.SGD","LU1718418525.SGD","BK4201","IE00BK4W5L77.USD","LU1430594728.SGD","LU1868837136.USD","BK4585","LU1868837300.USD","LU0787776722.HKD","LU1670711123.USD","LU0170899867.USD","BK4176","LU0985481810.HKD","LU2125154935.USD","LU0237698245.USD","LU0306807586.USD","LU0980610538.SGD","BMY","IE0002141913.USD","IE00BK4W5M84.HKD"],"gpt_icon":1},{"id":"2521815802","title":"Shell's Brazil Subsidiary Joins Consortium Developing Gato do Mato Offshore Project","url":"https://stock-news.laohu8.com/highlight/detail?id=2521815802","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521815802?lang=en_us&edition=fundamental","pubTime":"2025-03-21 21:09","pubTimestamp":1742562591,"startTime":"0","endTime":"0","summary":"Shell  said Friday its Brasil subsidiary, Shell Brazil Petroleo, has joined a consortium holding stakes in the Gato do Mato deep-water project in the pre-salt area of the Santos Basin offshore of Brazil's Rio de Janeiro coast.Financial details of the investment in joining the consortium weren't disclosed.The Gato do Mato consortium now includes Shell, as operator of the project, with a 50% stake; Ecopetrol , with a 30% stake; TotalEnergies , with a 20% stake and the Brazil government's public company under its Ministry of Mines and Energy, Pre-Sal Petroleo, acting as the manager of the contract, Shell said.The project's recoverable resource volumes are estimated at about 370 million barrels. The project includes installation of a floating production storage and offloading vessel, and is designed to produce up to 120,000 barrels of oil per day once it is anticipated to begin operations in 2029, Shell said.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2237443978.SGD","BK4588","BK4201","SHEL","LU2237443382.USD","LU0300736492.USD","LU2129689431.USD","LU2237443465.HKD","LU2237443549.SGD","LU0300736062.USD","LU1162221912.USD","LU2129689605.HKD","BK4561","LU2237443895.HKD","LU2129689514.USD","LU2236285917.USD","BK4585","LU0320765646.SGD","LU0098860793.USD","LU0278409577.USD","LU2237443622.USD","TTE","EC"],"gpt_icon":1},{"id":"2520458334","title":"Press Release: InflaRx Reports Full Year 2024 Results and Highlights Key Achievements and Expected Milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2520458334","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520458334?lang=en_us&edition=fundamental","pubTime":"2025-03-20 19:30","pubTimestamp":1742470200,"startTime":"0","endTime":"0","summary":"-- Received European Commission approval for GOHIBIC  for. the treatment of SARS-CoV-2-induced acute respiratory distress syndrome. pyoderma gangrenosum  to enable an expected interim analysis for. trial size adaptation or futility by the end of May 2025. -- Dosed first patient in Phase 2a trial for oral C5aR inhibitor, INF904,INF904 in CSU and HS -- Topline Phase 2a data expected in summer 2025. In December 2024, InflaRx announced that the first patient had been dosed in its Phase 2a basket study with INF904 in CSU and HS. This is a multi-center, open-label study evaluating multiple INF904 dosing regimens over 4 weeks of treatment in a total of 75 patients . The goal of the trial is to generate additional safety and pharmacokinetic  data and to provide signs of clinical benefit. After the 4-week treatment period, patients will be follow","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4201","LU0124676726.USD","LU0061475181.USD","ARDS","LU0868494617.USD","LU1868837136.USD","BK4022","IFRX","LU0098860793.USD","BK4585","LU1914381329.SGD","R","LU0320765646.SGD","LU1929549753.HKD","LU0640476718.USD","SG9999014567.USD","IE00BWXC8680.SGD","BK4018","BK4181","IE000M9KFDE8.USD","BK4567","LU0237698245.USD","LU0234572021.USD","LU1868836757.USD","LU2552382132.HKD","EC","LU0094547139.USD","LU0234570918.USD","LU1162221912.USD","LU1868837300.USD","IE00B1XK9C88.USD","LU0096364046.USD","LU1430594728.SGD","BK4139","LU2129689431.USD","LU2242652126.USD","LU0323591593.USD","BK4559","LU1585245621.USD","PK","BK4588","SG9999002224.SGD","PG","BK4218","SG9999002232.USD","IE00BLSP4452.SGD","LU0689626769.HKD","SG9999015341.SGD","IE00B3T34201.USD"],"gpt_icon":0},{"id":"2520193740","title":"Rhythm Pharmaceuticals Announces Orphan Drug Designation Granted to Setmelanotide for Treatment of Hypothalamic Obesity in Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2520193740","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520193740?lang=en_us&edition=fundamental","pubTime":"2025-03-20 04:01","pubTimestamp":1742414460,"startTime":"0","endTime":"0","summary":"BOSTON, March 19, 2025  -- Rhythm Pharmaceuticals, Inc. , a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced it has received orphan drug designation from Japan’s Ministry of Health, Labour and Welfare  for setmelanotide as a treatment for acquired hypothalamic obesity.Setmelanotide is a melanocortin-4 receptor  agonist designed to treat hyperphagia and obesity. Rhythm is evaluating setmelanotide in a global Phase 3 trial in patients with acquired hypothalamic obesity, with topline data on track to be disclosed in the second quarter of 2025.In Japan, drugs can be designated as orphan drugs if they treat diseases affecting fewer than 50,000 patients in Japan and there is a high medical need.Rhythm estimates there are 5,000 to 8,000 people living with acquired hypothalamic obesity in Japan, 5,000 to 10,000 people living with acquired hypothalamic obesity in the U.S., and 3,500 to 10,00","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/rhythm-pharmaceuticals-announces-orphan-drug-200100660.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["EC","BK4588","BK4139","BK4201","BK4585","RYTM"],"gpt_icon":0},{"id":"2520053342","title":"EC World REIT Announces New Property Management Agreements","url":"https://stock-news.laohu8.com/highlight/detail?id=2520053342","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520053342?lang=en_us&edition=fundamental","pubTime":"2025-03-17 08:12","pubTimestamp":1742170330,"startTime":"0","endTime":"0","summary":"The latest announcement is out from EC World Real Estate Investment Trust ( ($SG:BWCU) ). EC World Real Estate Investment Trust has announced new p...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ec-world-reit-announces-new-property-management-agreements?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ec-world-reit-announces-new-property-management-agreements?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ECWDF","BK4224","BK4201","EC","REIT","SG","BK4209"],"gpt_icon":0},{"id":"2520555574","title":"EC World Reit appoints new property managers, port operator","url":"https://stock-news.laohu8.com/highlight/detail?id=2520555574","media":"businesstimes","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520555574?lang=en_us&edition=fundamental","pubTime":"2025-03-17 01:50","pubTimestamp":1742147441,"startTime":"0","endTime":"0","summary":"The contract terms for the appointments are for one year ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"bustime_highlight","url":"https://www.businesstimes.com.sg/companies-markets/ec-world-reit-appoints-new-property-managers-port-operator","rn_cache_url":null,"customStyle":"","selectors":"body","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.businesstimes.com.sg/companies-markets/ec-world-reit-appoints-new-property-managers-port-operator","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"bustime_highlight","symbols":["CFA.SI","EC","BK4201"],"gpt_icon":0},{"id":"2519338297","title":"Bristol-Myers Squibb (NYSE:BMY) Gets EC Nod For Breyanzi In NHL Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2519338297","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519338297?lang=en_us&edition=fundamental","pubTime":"2025-03-15 01:27","pubTimestamp":1741973244,"startTime":"0","endTime":"0","summary":"Bristol-Myers Squibb recently gained European Commission approval for Breyanzi, broadening treatment options for indolent non-Hodgkin lymphoma, which was a significant recent event. During the last quarter, the company's stock rose by 8%, amid a backdrop of several key events and broader market trends. Positive results from the Phase 3 POETYK PsA-2 trial for Sotyktu and a substantial share buyback program may have bolstered investor confidence. Additionally, a quarterly dividend declaration continued to assure income-oriented investors. On a broader scale, market activity demonstrated volatility; however, the technology sector experienced a rally, and the Dow Jones Industrial Average rebounded, signaling a partial market recovery following a correction phase. These factors contributed to Bristol-Myers Squibb's share performance, as the company navigated a challenging but promising landscape with strategic product approvals and shareholder-focused actions.Gain insight into the risks fac","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bristol-myers-squibb-nyse-bmy-172724887.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0321505439.SGD","LU1032466523.USD","LU0868494617.USD","LU0096364046.USD","LU2133065610.SGD","LU2242652126.USD","LU1868836757.USD","LU1430594728.SGD","LU2125154935.USD","LU2242646821.SGD","BMY","LU0306807586.USD","LU1093756168.USD","LU1670710588.SGD","IE00B2B36J28.USD","LU1670711040.USD","IE00BJJMRZ35.SGD","LU0985481810.HKD","LU1323610961.USD","LU0306806265.USD","LU1585245621.USD","IE00BFXG1179.USD","LU1261432733.SGD","LU0456855351.SGD","LU1868837300.USD","LU1868837136.USD","IE00BJT1NW94.SGD","BK4201","BK4007","IE0002141913.USD","IE00BFTCPJ56.SGD","BK4559","LU1670711123.USD","BK4581","LU0114720955.EUR","LU1868836591.USD","LU2360032135.SGD","LU1291159041.SGD","BK4532","LU0061475181.USD","EC","LU0237698245.USD","NYSE","BK4534","LU0882574055.USD","IE00BSNM7G36.USD","LU2125154778.USD","BK4588","LU0225284248.USD","BK4585"],"gpt_icon":0},{"id":"2519872049","title":"Bristol Myers announces EC approval of Breyanzi","url":"https://stock-news.laohu8.com/highlight/detail?id=2519872049","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519872049?lang=en_us&edition=fundamental","pubTime":"2025-03-14 19:06","pubTimestamp":1741950373,"startTime":"0","endTime":"0","summary":"Bristol Myers (BMY) Squibb announced that the European Commission has granted approval to Breyanzi, a CD19-directed chimeric antigen receptor T cel...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bristol-myers-announces-ec-approval-of-breyanzi?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bristol-myers-announces-ec-approval-of-breyanzi?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0321505439.SGD","LU0868494617.USD","LU2133065610.SGD","LU2242652126.USD","LU1868836757.USD","LU2125154935.USD","LU2242646821.SGD","BMY","LU0306807586.USD","LU1093756168.USD","LU1670710588.SGD","IE00B2B36J28.USD","LU1670711040.USD","IE00BJJMRZ35.SGD","MYE","LU0985481810.HKD","LU0225771236.USD","LU1323610961.USD","LU0306806265.USD","LU0321505868.SGD","LU1585245621.USD","IE00BFXG1179.USD","LU1261432733.SGD","LU1868837300.USD","LU1718418525.SGD","LU1868837136.USD","LU1868836914.USD","BK4201","IE0002141913.USD","BK4559","LU1670711123.USD","BK4581","LU0114720955.EUR","LU1868836591.USD","LU2360032135.SGD","LU1291159041.SGD","LU1074936037.SGD","BK4532","EC","LU0237698245.USD","LU1571399168.USD","BK4126","BK4534","LU0882574055.USD","IE00BSNM7G36.USD","LU2125154778.USD","LU1093756325.SGD","BK4588","LU1670710661.SGD","BK4585"],"gpt_icon":0},{"id":"2519808851","title":"Bristol Myers Squibb Receives Approval from the European Commission to Expand Use of CAR T Cell Therapy Breyanzi for Relapsed or Refractory Follicular Lymphoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2519808851","media":"Business Wire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519808851?lang=en_us&edition=fundamental","pubTime":"2025-03-14 18:59","pubTimestamp":1741949940,"startTime":"0","endTime":"0","summary":"In the TRANSCEND FL trial, 97.1% of patients responded to Breyanzi, with 94.2% of patients achieving complete response*. Breyanzi demonstrated sustained clinical benefit, with 75.7% of patients still in response at 18 months, and a consistent safety profile with no new safety signals observed. PRINCETON, N.J., March 14, 2025----Bristol Myers Squibb  today announced that the European Commission  has granted approval to Breyanzi , a CD19-directed chimeric antigen receptor  T cell therapy, for the treatment of adult patients with relapsed or refractory follicular lymphoma  after two or more lines of systemic therapy.This expanded approval is applicable to all European Union  member states as well as the European Economic Area  countries Iceland, Norway and Liechtenstein.** Breyanzi is also approved in the EU for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma , high grade B-cell lymphoma , primary mediastinal large B-cell lymphoma  and FL grade 3B","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bristol-myers-squibb-receives-approval-105900919.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4205","CRS","LU1032466523.USD","LU0456855351.SGD","EEA","LU1718418525.SGD","LU0882574055.USD","BMY","BK4534","EC","IE0031619046.USD","IE00BJJMRZ35.SGD","LU2360032135.SGD","LU0306806265.USD","IE00BFXG1179.USD","LU0237698245.USD","LU2125154935.USD","LU1430594728.SGD","IE00BSNM7G36.USD","LU2125154778.USD","LU2242652126.USD","LU0114720955.EUR","LU2065731478.USD","BK4201","IE00BFTCPJ56.SGD","FL","BK4588","LU0096364046.USD","LU2133065610.SGD","LU1261432733.SGD","BK4156","LU1323610961.USD","BK4094","BK4585","BK4230","HSCT","BK4528","LU1093756325.SGD","LU1670711040.USD","UK","LU2242646821.SGD","LU1585245621.USD","CAR","LU0868494617.USD","CR","MYE","LU0225771236.USD","IE00B66KJ199.SGD","LU0061475181.USD"],"gpt_icon":0},{"id":"2519389886","title":"Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2024 and Provides a Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2519389886","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519389886?lang=en_us&edition=fundamental","pubTime":"2025-03-14 06:07","pubTimestamp":1741903620,"startTime":"0","endTime":"0","summary":"○ UCART22 Phase 1 dataset and late-stage development strategy expected in the third quarter of 2025; Orphan Drug Designation (ODD) and Rare Pediatric Disease Designation (RPDD) granted by FDA and ODD ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/13/3042670/0/en/Cellectis-Reports-Financial-Results-for-the-Fourth-Quarter-and-Full-Year-2024-and-Provides-a-Business-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4230","RCC","BK4201","BK4080","CAR","CLLS","BK4183","BK4139","ODD","SITC","EC","BK4022","BK4231"],"gpt_icon":0},{"id":"2519007017","title":"Rxulti® (brexpiprazole) approved in the European Union for the treatment of schizophrenia in adolescents aged 13 years and older","url":"https://stock-news.laohu8.com/highlight/detail?id=2519007017","media":"PR Newswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519007017?lang=en_us&edition=fundamental","pubTime":"2025-03-13 16:45","pubTimestamp":1741855500,"startTime":"0","endTime":"0","summary":"Brexpiprazole's indication for the treatment of schizophrenia in adults is extended to include adolescents aged 13 years and older1. Approval follows a positive Committee for Medicinal Products for Human Use  opinion from the European Medicines Agency in January 20252. Treatment with brexpiprazole  significantly reduced the symptoms of schizophrenia as measured by PANSS total score compared to placebo3. WINDSOR, England and VALBY, Denmark, March 13, 2025 /PRNewswire/ --Otsuka Pharmaceutical Europe Ltd.  and H. Lundbeck A/S  today announced that the European Commission  has approved Rxulti for the treatment of schizophrenia in adolescents aged 13 years and older.1 Brexpiprazolewas previously approved in the European Union in 2018 for the treatment of schizophrenia in adults.4. Brexpiprazole was discovered by Otsuka and is being co-developed and co-commercialised under a collaboration and license agreement between Otsuka Pharmaceutical Europe Ltd. a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/rxulti-brexpiprazole-approved-european-union-084500819.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/rxulti-brexpiprazole-approved-european-union-084500819.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["HLBBF","HLUBF","EC","CHMP","BK4007","BK4087","BK4201"],"gpt_icon":0},{"id":"2518570777","title":"Geron Announces European Commission Approval of RYTELO® (imetelstat), a First-in-Class Telomerase Inhibitor, for the Treatment of Adults With Transfusion-Dependent Anemia Due to Lower-Risk MDS","url":"https://stock-news.laohu8.com/highlight/detail?id=2518570777","media":"Business Wire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518570777?lang=en_us&edition=fundamental","pubTime":"2025-03-12 04:30","pubTimestamp":1741725000,"startTime":"0","endTime":"0","summary":"RYTELO is the first and only telomerase inhibitor approved in the U.S. and Europe. FOSTER CITY, Calif., March 11, 2025----Geron Corporation , a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that the European Commission  has granted marketing authorization for RYTELO  as a monotherapy for the treatment of adult patients with transfusion-dependent  anemia due to very low, low or intermediate risk myelodysplastic syndromes  without an isolated deletion 5q cytogenetic  abnormality and who had an unsatisfactory response to or are ineligible for erythropoietin-based therapy . Lower-risk MDS is a progressive blood cancer with high unmet need, where many patients with anemia become dependent on red blood cell transfusions, which can be associated with clinical consequences and decreased quality of life.The marketing authorization of RYTELO approved by the EC is supported by data from the IMerge Phase 3 clinical trial, ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/geron-announces-european-commission-approval-203000014.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","BK4539","GERN","BK4207","BK4139","BK4006","EC","TD","BK4079","BK4566","RS","BK4201","COMP"],"gpt_icon":0},{"id":"2518747046","title":"Petrobras' Board Approves $283 Million Settlement Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2518747046","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518747046?lang=en_us&edition=fundamental","pubTime":"2025-03-11 20:23","pubTimestamp":1741695780,"startTime":"0","endTime":"0","summary":"Petrobras PBR, Brazil’s state-run oil and gas company, has announced that its board has approved an agreement to settle a longstanding legal dispute with EIG Energy Fund XIV in a U.S. court. As part of this agreement, the Brazilian company will make a $283 million payment to resolve the issue. This decision marks a significant development for Petrobras as it addresses legal matters related to past investments.In a securities filing, the integrated oil and gas company confirmed that this contingency has been provisioned in its earnings. This ensures that the company is prepared for the financial implications of the settlement. By making this payment, PBR aims to resolve the issue efficiently, allowing it to focus on the ongoing operations without further legal distractions.Last year, PBR disclosed that it made two significant gas discoveries in the Guajira offshore basin in Colombia, which dramatically raised the gas potential in the region to an estimate","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/petrobras-board-approves-283-million-122300320.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2498475776.HKD","BK4548","AROC","AR","LU1051768304.USD","BK4179","LU0788109048.HKD","LU0256859116.SGD","BK4585","IE00B1B80R65.USD","LU0572108347.SGD","BK4201","LU1051769294.HKD","LU2462611646.USD","LU0265266980.USD","LU0072463663.USD","BK4213","BK4588","LU0106259046.USD","LU1883866441.USD","EC","LU0651946864.USD","LU0651947912.USD","PBR","LU1515016050.SGD"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EC\",params:#limit:5,,,undefined,":[{"date":"2025-08-12","symbol":"EC","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/06","expectedEps":0.41,"defaultRemindTime":1755028800000,"name":null,"time":"Post Market","dateTimestamp":1754971200000,"actualEps":null},{"market":"US","date":"2025-05-06","symbol":"EC","fiscalQuarterEnding":"2025/03","expectedEps":0.36,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746504000000,"reportTimeType":"post","actualEps":0.5},{"date":"2025-04-28","symbol":"EC","amount":0.5202,"announcedDate":"2025-03-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-04-28","defaultRemindTime":1745847000000,"name":"哥伦比亚国家石油","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-06","payableDate":"2025-04-28","currency":"USD","dateTimestamp":1745812800000,"payDate":"2025-05-06"},{"date":"2025-04-03","symbol":"EC","amount":0.5202,"announcedDate":"2025-03-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-04-03","defaultRemindTime":1743687000000,"name":"哥伦比亚国家石油","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-11","payableDate":"2025-04-03","currency":"USD","dateTimestamp":1743652800000,"payDate":"2025-04-11"},{"market":"US","date":"2025-03-04","symbol":"EC","fiscalQuarterEnding":"2024/12","expectedEps":0.36,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1741064400000,"reportTimeType":"post","actualEps":0.74}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EC\",market:\"US\",,,undefined,":[{"executeDate":"2017-04-25","recordDate":"2017-04-27","paymentDate":"2017-05-08","value":0.160581,"currency":"USD"},{"executeDate":"2018-04-17","recordDate":"2018-04-18","paymentDate":"2018-04-27","value":0.605505,"currency":"USD"},{"executeDate":"2019-04-23","recordDate":"2019-04-24","paymentDate":"2019-05-03","value":1.0849538,"currency":"USD"},{"executeDate":"2019-12-26","recordDate":"2019-12-27","paymentDate":"2020-01-02","value":0.4861737,"currency":"USD"},{"executeDate":"2020-04-21","recordDate":"2020-04-22","paymentDate":"2020-05-01","value":0.8938347,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"EC\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1,"buy":0,"hold":0.5,"sell":0.3,"strongSell":0.1,"meanLabel":"HOLD","meanPercent":0.5,"analysts":10,"updateTime":1751515200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/EC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"EC","date":"2025-07-31","current":5.194436,"percent":0.489829,"low":2.588919,"twenty":3.860032,"median":5.230878,"eighty":12.825744,"high":64.266012,"avg":9.739825,"sd":11.480982,"marketCap":17474053793.7},"quantilePoints":[{"date":"2020-08-07","current":11.632318,"twenty":-8.057144,"median":10.172576,"eighty":13.640183,"marketCap":23832899932.5},{"date":"2020-08-14","current":11.793133,"twenty":-8.057144,"median":10.192421,"eighty":13.629769,"marketCap":23903159981.5},{"date":"2020-08-21","current":11.685923,"twenty":-8.057144,"median":10.231601,"eighty":13.619393,"marketCap":23443635095.52},{"date":"2020-08-28","current":11.65912,"twenty":-8.057144,"median":10.270329,"eighty":13.617103,"marketCap":23779198827.58},{"date":"2020-09-04","current":11.498305,"twenty":-8.057144,"median":10.284523,"eighty":13.609447,"marketCap":23776806974.38},{"date":"2020-09-11","current":10.855043,"twenty":-8.057144,"median":10.291369,"eighty":13.600215,"marketCap":22417626544.05},{"date":"2020-09-18","current":11.337489,"twenty":-8.057144,"median":10.314383,"eighty":13.584791,"marketCap":23327291308.61},{"date":"2020-09-25","current":10.292189,"twenty":-8.057144,"median":10.319805,"eighty":13.561711,"marketCap":20378443894.99},{"date":"2020-10-02","current":10.238584,"twenty":-8.057144,"median":10.314383,"eighty":13.538631,"marketCap":20154725229.8},{"date":"2020-10-09","current":10.388678,"twenty":-8.057144,"median":10.308961,"eighty":13.478624,"marketCap":20836271816.86},{"date":"2020-10-16","current":10.077768,"twenty":-8.057144,"median":10.29616,"eighty":13.39092,"marketCap":20097076675.56},{"date":"2020-10-23","current":9.970558,"twenty":-8.057144,"median":10.291369,"eighty":13.344761,"marketCap":20240056139.58},{"date":"2020-10-30","current":13.354362,"twenty":-8.045382,"median":10.291779,"eighty":13.339443,"marketCap":19098996340.43},{"date":"2020-11-06","current":13.66753,"twenty":-8.027739,"median":10.300132,"eighty":13.478624,"marketCap":20189365488.02},{"date":"2020-11-13","current":14.912744,"twenty":-8.027739,"median":10.319805,"eighty":13.590618,"marketCap":22610846979.57},{"date":"2020-11-20","current":16.053569,"twenty":-8.027739,"median":10.344145,"eighty":13.620537,"marketCap":24261858653.1},{"date":"2020-11-27","current":16.19524,"twenty":-8.027739,"median":10.361737,"eighty":13.641085,"marketCap":24731503978.59},{"date":"2020-12-04","current":16.500951,"twenty":-8.027739,"median":10.372727,"eighty":13.68258,"marketCap":26223772364.1},{"date":"2020-12-11","current":17.224219,"twenty":-8.027739,"median":10.388678,"eighty":13.70689,"marketCap":27667442900.73},{"date":"2020-12-18","current":17.343521,"twenty":-8.027739,"median":10.399188,"eighty":13.778662,"marketCap":27962526123.89},{"date":"2020-12-24","current":17.052723,"twenty":-8.027739,"median":10.415218,"eighty":13.826153,"marketCap":26881415841.75},{"date":"2020-12-31","current":16.739555,"twenty":-8.027739,"median":10.428877,"eighty":13.864693,"marketCap":26994291439.99},{"date":"2021-01-08","current":17.887837,"twenty":-8.027739,"median":10.443632,"eighty":13.884097,"marketCap":28336383384.46},{"date":"2021-01-15","current":18.04442,"twenty":-8.004214,"median":10.45629,"eighty":13.94086,"marketCap":28718079297.45},{"date":"2021-01-22","current":17.5523,"twenty":-7.998333,"median":10.472905,"eighty":13.9633,"marketCap":27428996316},{"date":"2021-01-29","current":15.136435,"twenty":-7.998333,"median":10.484881,"eighty":13.996226,"marketCap":23416813550.86},{"date":"2021-02-05","current":16.068482,"twenty":-7.998333,"median":10.499343,"eighty":14.123084,"marketCap":25042104133.89},{"date":"2021-02-12","current":16.0312,"twenty":-7.998333,"median":10.512522,"eighty":14.180251,"marketCap":25204109478.1},{"date":"2021-02-19","current":16.143045,"twenty":-7.986571,"median":10.513852,"eighty":14.217179,"marketCap":25046465773.01},{"date":"2021-02-26","current":58.305857,"twenty":-7.968927,"median":10.548119,"eighty":14.277186,"marketCap":25507337685.76},{"date":"2021-03-05","current":62.192915,"twenty":-7.968927,"median":10.549134,"eighty":14.309498,"marketCap":27185340438.03},{"date":"2021-03-12","current":61.622813,"twenty":-7.968927,"median":10.55525,"eighty":14.383353,"marketCap":27404215357.16},{"date":"2021-03-19","current":61.415503,"twenty":-7.968927,"median":10.560215,"eighty":14.424897,"marketCap":27381860856.27},{"date":"2021-03-26","current":60.923143,"twenty":-7.968927,"median":10.566774,"eighty":14.471057,"marketCap":26275612062.35},{"date":"2021-04-01","current":61.311848,"twenty":-7.968927,"median":10.569887,"eighty":14.506881,"marketCap":26583440261.39},{"date":"2021-04-09","current":58.564995,"twenty":-7.963046,"median":10.584415,"eighty":14.560475,"marketCap":25527094664.96},{"date":"2021-04-16","current":59.627457,"twenty":-7.939522,"median":10.587425,"eighty":14.602488,"marketCap":26281880793.85},{"date":"2021-04-23","current":57.735756,"twenty":-7.939522,"median":10.608026,"eighty":14.657491,"marketCap":25100144058.23},{"date":"2021-04-30","current":57.269309,"twenty":-7.939522,"median":10.61798,"eighty":14.744064,"marketCap":24302726735.73},{"date":"2021-05-07","current":20.722698,"twenty":-7.939522,"median":10.625618,"eighty":14.842782,"marketCap":25005315360.88},{"date":"2021-05-14","current":21.619353,"twenty":-7.933641,"median":10.625618,"eighty":15.002221,"marketCap":26643921768.12},{"date":"2021-05-21","current":20.695527,"twenty":-7.904235,"median":10.640622,"eighty":15.167685,"marketCap":25157084391.01},{"date":"2021-05-28","current":20.025299,"twenty":-7.88071,"median":10.65789,"eighty":15.365348,"marketCap":24472773564.38},{"date":"2021-06-04","current":21.329525,"twenty":-7.88071,"median":10.669598,"eighty":15.402274,"marketCap":26866573068.16},{"date":"2021-06-11","current":21.655582,"twenty":-7.88071,"median":10.685426,"eighty":15.557539,"marketCap":27175480153.64},{"date":"2021-06-18","current":21.709924,"twenty":-7.88071,"median":10.704782,"eighty":15.583818,"marketCap":26245397627.8},{"date":"2021-06-25","current":25.088231,"twenty":-7.88071,"median":10.720006,"eighty":15.743857,"marketCap":30460069078.47},{"date":"2021-07-02","current":25.821858,"twenty":-7.851305,"median":10.727521,"eighty":15.919354,"marketCap":31007458421.16},{"date":"2021-07-09","current":25.006717,"twenty":-7.804255,"median":10.758908,"eighty":15.993918,"marketCap":29565641596.76},{"date":"2021-07-16","current":23.186235,"twenty":-7.792493,"median":10.78369,"eighty":16.056552,"marketCap":27597991192.03},{"date":"2021-07-23","current":23.104721,"twenty":1.744237,"median":10.795303,"eighty":16.096961,"marketCap":27080627944.38},{"date":"2021-07-30","current":23.847405,"twenty":4.224151,"median":10.801539,"eighty":16.246916,"marketCap":28048152007.56},{"date":"2021-08-06","current":12.710961,"twenty":4.403647,"median":10.812794,"eighty":16.246916,"marketCap":26445510448.34},{"date":"2021-08-13","current":12.905593,"twenty":4.442538,"median":10.823748,"eighty":16.240705,"marketCap":27744434941.12},{"date":"2021-08-20","current":12.656065,"twenty":4.657934,"median":10.823748,"eighty":16.204333,"marketCap":26967345402.64},{"date":"2021-08-27","current":13.274894,"twenty":4.807514,"median":10.828241,"eighty":16.153484,"marketCap":28519011180.03},{"date":"2021-09-03","current":13.15013,"twenty":5.094709,"median":10.857136,"eighty":16.096961,"marketCap":28507430734.94},{"date":"2021-09-10","current":12.740904,"twenty":5.313096,"median":10.873763,"eighty":16.08544,"marketCap":27364682362.77},{"date":"2021-09-17","current":12.805782,"twenty":5.45071,"median":10.889499,"eighty":16.079739,"marketCap":27601161170.58},{"date":"2021-09-24","current":12.725933,"twenty":5.492593,"median":10.924728,"eighty":16.071464,"marketCap":27244457816.11},{"date":"2021-10-01","current":13.818866,"twenty":5.504559,"median":10.92749,"eighty":16.059534,"marketCap":30101294872.59},{"date":"2021-10-08","current":14.512554,"twenty":5.540458,"median":10.942084,"eighty":16.040148,"marketCap":31766032985.79},{"date":"2021-10-15","current":14.772063,"twenty":5.636189,"median":10.962071,"eighty":16.008831,"marketCap":32297167497.92},{"date":"2021-10-22","current":14.422724,"twenty":5.69303,"median":10.9698,"eighty":15.993918,"marketCap":31388448015.98},{"date":"2021-10-29","current":14.208129,"twenty":5.707988,"median":10.982384,"eighty":15.993918,"marketCap":30938584888.05},{"date":"2021-11-05","current":14.357846,"twenty":5.731921,"median":11.005297,"eighty":15.971549,"marketCap":30508260850.86},{"date":"2021-11-12","current":10.821451,"twenty":5.779787,"median":10.996652,"eighty":15.934267,"marketCap":30028393272.71},{"date":"2021-11-19","current":10.078429,"twenty":5.80372,"median":10.978125,"eighty":15.919354,"marketCap":27735497042.93},{"date":"2021-11-26","current":9.663099,"twenty":5.815686,"median":10.9698,"eighty":15.901459,"marketCap":25946683687.22},{"date":"2021-12-03","current":10.139395,"twenty":5.833636,"median":10.962253,"eighty":15.859703,"marketCap":27663402839.39},{"date":"2021-12-10","current":10.314672,"twenty":5.833636,"median":10.946258,"eighty":15.825404,"marketCap":28555311336.09},{"date":"2021-12-17","current":10.078429,"twenty":5.845602,"median":10.937911,"eighty":15.782048,"marketCap":27314059035.32},{"date":"2021-12-23","current":10.097481,"twenty":5.872527,"median":10.92749,"eighty":15.71334,"marketCap":27258209523.55},{"date":"2021-12-31","current":10.249896,"twenty":5.911418,"median":10.917433,"eighty":15.590738,"marketCap":27187431472.42},{"date":"2022-01-07","current":10.101291,"twenty":5.926376,"median":10.889499,"eighty":15.588592,"marketCap":26932288402.65},{"date":"2022-01-14","current":10.672847,"twenty":5.941334,"median":10.873763,"eighty":15.587637,"marketCap":28758892730.03},{"date":"2022-01-21","current":10.863365,"twenty":5.9533,"median":10.875619,"eighty":15.583818,"marketCap":29601943576.06},{"date":"2022-01-28","current":10.996728,"twenty":6.102881,"median":10.889499,"eighty":15.583818,"marketCap":29787077559.89},{"date":"2022-02-04","current":11.053884,"twenty":6.177671,"median":10.911516,"eighty":15.557539,"marketCap":30226428284.35},{"date":"2022-02-11","current":11.32442,"twenty":6.204595,"median":10.924728,"eighty":15.557539,"marketCap":31213777266},{"date":"2022-02-18","current":11.419679,"twenty":6.264427,"median":10.942084,"eighty":15.557539,"marketCap":31437797276.81},{"date":"2022-02-25","current":11.674974,"twenty":6.719152,"median":10.966026,"eighty":15.557539,"marketCap":32235185643.05},{"date":"2022-03-04","current":8.775545,"twenty":7.060195,"median":10.9698,"eighty":15.557539,"marketCap":35993542030.87},{"date":"2022-03-11","current":8.93319,"twenty":7.246521,"median":10.9698,"eighty":15.557539,"marketCap":36596969016.47},{"date":"2022-03-18","current":8.591626,"twenty":7.364711,"median":10.9698,"eighty":15.557539,"marketCap":35253970222.95},{"date":"2022-03-25","current":9.432397,"twenty":7.512449,"median":10.9698,"eighty":15.557539,"marketCap":38980889412.18},{"date":"2022-04-01","current":9.274753,"twenty":7.608478,"median":10.9698,"eighty":15.557539,"marketCap":38450231073.35},{"date":"2022-04-08","current":9.379849,"twenty":7.682347,"median":10.9698,"eighty":15.557539,"marketCap":38840654118.15},{"date":"2022-04-14","current":8.79131,"twenty":7.734055,"median":10.9698,"eighty":15.557539,"marketCap":36814680340.58},{"date":"2022-04-22","current":8.814956,"twenty":7.848551,"median":10.9698,"eighty":15.557539,"marketCap":36083314330.36},{"date":"2022-04-29","current":8.423472,"twenty":7.937194,"median":10.9698,"eighty":15.557539,"marketCap":33232522355.71},{"date":"2022-05-06","current":8.612646,"twenty":8.036916,"median":10.9698,"eighty":15.557539,"marketCap":33355736677.76},{"date":"2022-05-13","current":6.665183,"twenty":8.103632,"median":10.9698,"eighty":15.557539,"marketCap":31053756069.43},{"date":"2022-05-20","current":6.100082,"twenty":8.103632,"median":10.9698,"eighty":15.557539,"marketCap":29215441427.83},{"date":"2022-05-27","current":6.443869,"twenty":8.103632,"median":10.9698,"eighty":15.557539,"marketCap":31633906458.52},{"date":"2022-06-03","current":7.09062,"twenty":8.103632,"median":10.9698,"eighty":15.557539,"marketCap":36015579040.45},{"date":"2022-06-10","current":6.768319,"twenty":8.103632,"median":10.9698,"eighty":15.557539,"marketCap":33175611750.38},{"date":"2022-06-17","current":5.930337,"twenty":8.103632,"median":10.9698,"eighty":15.557539,"marketCap":29053271209.52},{"date":"2022-06-24","current":4.596011,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":21309510065.4},{"date":"2022-07-01","current":5.049381,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":23031543041.38},{"date":"2022-07-08","current":4.941947,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":21588001138.43},{"date":"2022-07-15","current":4.507915,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":19716315930.61},{"date":"2022-07-22","current":4.426266,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":19171225427.54},{"date":"2022-07-29","current":4.898974,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":21883856364.26},{"date":"2022-08-05","current":3.574458,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":21338876009.71},{"date":"2022-08-12","current":3.730145,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":23041049912.2},{"date":"2022-08-19","current":3.601465,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":21140719616.75},{"date":"2022-08-26","current":3.841351,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":22629951917.79},{"date":"2022-09-02","current":3.650713,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":21012334466.97},{"date":"2022-09-09","current":3.704727,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":21967588896.88},{"date":"2022-09-16","current":3.65389,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":21341487133.73},{"date":"2022-09-23","current":3.23131,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":18854575930.98},{"date":"2022-09-30","current":3.294856,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":18534639915.46},{"date":"2022-10-07","current":3.717436,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":20860105711.81},{"date":"2022-10-14","current":3.431479,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":19210084039.28},{"date":"2022-10-21","current":3.738088,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":19779927748.93},{"date":"2022-10-28","current":3.828641,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":20554935737.41},{"date":"2022-11-04","current":4.035166,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":20491789367.72},{"date":"2022-11-11","current":3.24681,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":20458414210.6},{"date":"2022-11-18","current":3.361163,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":20337590990.79},{"date":"2022-11-25","current":3.344827,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":20723664325.37},{"date":"2022-12-02","current":3.127012,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":19844314857.84},{"date":"2022-12-09","current":2.988155,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":18750367698.78},{"date":"2022-12-16","current":2.903751,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":18284182498.81},{"date":"2022-12-23","current":3.131096,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":19947772061.04},{"date":"2022-12-30","current":3.294457,"twenty":8.121847,"median":10.9698,"eighty":15.557539,"marketCap":20529504239.87},{"date":"2023-01-06","current":3.602122,"twenty":7.977821,"median":10.962071,"eighty":15.448048,"marketCap":22389902276.09},{"date":"2023-01-13","current":3.694693,"twenty":7.915033,"median":10.92749,"eighty":15.353601,"marketCap":23782172411.38},{"date":"2023-01-20","current":3.74234,"twenty":7.848551,"median":10.9129,"eighty":15.15206,"marketCap":24396148087.2},{"date":"2023-01-27","current":3.549029,"twenty":7.730361,"median":10.871907,"eighty":14.912744,"marketCap":23576646443.82},{"date":"2023-02-03","current":3.453735,"twenty":7.67496,"median":10.855043,"eighty":14.784787,"marketCap":22203715289.17},{"date":"2023-02-10","current":3.578979,"twenty":7.608478,"median":10.823748,"eighty":14.726178,"marketCap":22573097153.72},{"date":"2023-02-17","current":3.452374,"twenty":7.460741,"median":10.819131,"eighty":14.657544,"marketCap":21286938129.56},{"date":"2023-02-24","current":3.566727,"twenty":7.361018,"median":10.801539,"eighty":14.626454,"marketCap":22170808225.69},{"date":"2023-03-03","current":3.545128,"twenty":7.216974,"median":10.78369,"eighty":14.586838,"marketCap":23427703717.77},{"date":"2023-03-10","current":3.317459,"twenty":7.088595,"median":10.7295,"eighty":14.524941,"marketCap":22187614317.96},{"date":"2023-03-17","current":3.122315,"twenty":7.0094,"median":10.713578,"eighty":14.500509,"marketCap":20406573454.93},{"date":"2023-03-24","current":2.988315,"twenty":6.781898,"median":10.678394,"eighty":14.458692,"marketCap":19971462825.74},{"date":"2023-03-31","current":3.187363,"twenty":6.671286,"median":10.65789,"eighty":14.423159,"marketCap":21760504177.85},{"date":"2023-04-06","current":3.30445,"twenty":6.650793,"median":10.635059,"eighty":14.418662,"marketCap":22872624729},{"date":"2023-04-14","current":3.334372,"twenty":6.418945,"median":10.625618,"eighty":14.355658,"marketCap":23842101468.43},{"date":"2023-04-21","current":3.27843,"twenty":6.252461,"median":10.590434,"eighty":14.307221,"marketCap":22859238559.53},{"date":"2023-04-28","current":2.84651,"twenty":6.208833,"median":10.584415,"eighty":14.251173,"marketCap":19349032795.29},{"date":"2023-05-05","current":2.588919,"twenty":6.139878,"median":10.566774,"eighty":14.215464,"marketCap":17727705001.21},{"date":"2023-05-12","current":2.799899,"twenty":5.947317,"median":10.55525,"eighty":14.180251,"marketCap":18718310549.59},{"date":"2023-05-19","current":2.830711,"twenty":5.851586,"median":10.547103,"eighty":14.107762,"marketCap":19231782153.84},{"date":"2023-05-26","current":2.794541,"twenty":5.779787,"median":10.513852,"eighty":14.036335,"marketCap":19186073980.7},{"date":"2023-06-02","current":2.765068,"twenty":5.636189,"median":10.502473,"eighty":13.996226,"marketCap":19252463212.38},{"date":"2023-06-09","current":2.908412,"twenty":5.338256,"median":10.484881,"eighty":13.941499,"marketCap":21397594307.35},{"date":"2023-06-16","current":2.884224,"twenty":4.96902,"median":10.443632,"eighty":13.927233,"marketCap":21241570166.18},{"date":"2023-06-23","current":2.877526,"twenty":4.924758,"median":10.424038,"eighty":13.931562,"marketCap":21499710361.53},{"date":"2023-06-30","current":2.884224,"twenty":4.886941,"median":10.390367,"eighty":13.91118,"marketCap":21130530306.86},{"date":"2023-07-07","current":2.853413,"twenty":4.835802,"median":10.372727,"eighty":13.879481,"marketCap":20797568199.88},{"date":"2023-07-14","current":2.995414,"twenty":4.714842,"median":10.361737,"eighty":13.869409,"marketCap":22415987059.75},{"date":"2023-07-21","current":2.921734,"twenty":4.596011,"median":10.322954,"eighty":13.870981,"marketCap":22516260606.85},{"date":"2023-07-28","current":2.945847,"twenty":4.507915,"median":10.29616,"eighty":13.863121,"marketCap":23012958238.52},{"date":"2023-08-04","current":3.121339,"twenty":4.248084,"median":10.286261,"eighty":13.696764,"marketCap":23184235668.09},{"date":"2023-08-11","current":3.839397,"twenty":4.000076,"median":10.267916,"eighty":13.604343,"marketCap":23607572072.62},{"date":"2023-08-18","current":3.885026,"twenty":3.90194,"median":10.240429,"eighty":13.50446,"marketCap":23091698704.87},{"date":"2023-08-25","current":3.896866,"twenty":3.896866,"median":10.224768,"eighty":13.50446,"marketCap":23283897302.7},{"date":"2023-09-01","current":3.986507,"twenty":3.896866,"median":10.181829,"eighty":13.50446,"marketCap":23647467030.48},{"date":"2023-09-08","current":4.033865,"twenty":3.896866,"median":10.143425,"eighty":13.50446,"marketCap":24250288549.3},{"date":"2023-09-15","current":4.15395,"twenty":3.896866,"median":10.123411,"eighty":13.354362,"marketCap":25668539731.74},{"date":"2023-09-22","current":4.174247,"twenty":3.896866,"median":10.099573,"eighty":13.274894,"marketCap":25723339627.09},{"date":"2023-09-29","current":3.945915,"twenty":3.896866,"median":10.078098,"eighty":13.15013,"marketCap":23472544770.05},{"date":"2023-10-06","current":3.925618,"twenty":3.896866,"median":10.071608,"eighty":13.050319,"marketCap":21839950653.49},{"date":"2023-10-12","current":4.240209,"twenty":3.896866,"median":10.039952,"eighty":12.940527,"marketCap":24300899049.42},{"date":"2023-10-20","current":4.42964,"twenty":3.89593,"median":9.98317,"eighty":12.884329,"marketCap":25310163915.08},{"date":"2023-10-27","current":4.186086,"twenty":3.893123,"median":9.960618,"eighty":12.82556,"marketCap":24462456576.38},{"date":"2023-11-03","current":4.194543,"twenty":3.893123,"median":9.927672,"eighty":12.803786,"marketCap":25266844123.99},{"date":"2023-11-10","current":4.85945,"twenty":3.893123,"median":9.909277,"eighty":12.803786,"marketCap":23963749044.29},{"date":"2023-11-17","current":4.952503,"twenty":3.893123,"median":9.902932,"eighty":12.803786,"marketCap":24118759651.85},{"date":"2023-11-24","current":5.169817,"twenty":3.893123,"median":9.891721,"eighty":12.803786,"marketCap":25265887504.92},{"date":"2023-12-01","current":5.211175,"twenty":3.893123,"median":9.879822,"eighty":12.803786,"marketCap":25611546029.96},{"date":"2023-12-08","current":5.097439,"twenty":3.894059,"median":9.834565,"eighty":12.801789,"marketCap":25297686803.83},{"date":"2023-12-15","current":5.283553,"twenty":3.894059,"median":9.834565,"eighty":12.801789,"marketCap":26543991442.74},{"date":"2023-12-22","current":4.869967,"twenty":3.894059,"median":9.834565,"eighty":12.801789,"marketCap":24577966848.99},{"date":"2023-12-29","current":4.838949,"twenty":3.893123,"median":9.836153,"eighty":12.803786,"marketCap":25178756823.67},{"date":"2024-01-05","current":4.973364,"twenty":3.892187,"median":9.837742,"eighty":12.805782,"marketCap":25160462757.48},{"date":"2024-01-12","current":4.869967,"twenty":3.892187,"median":9.837742,"eighty":12.805782,"marketCap":24641765108.78},{"date":"2024-01-19","current":4.756231,"twenty":3.892187,"median":9.844654,"eighty":12.807778,"marketCap":24078522670.15},{"date":"2024-01-26","current":4.869967,"twenty":3.892187,"median":9.837742,"eighty":12.805782,"marketCap":24572977032.09},{"date":"2024-02-02","current":4.849288,"twenty":3.892187,"median":9.837742,"eighty":12.805782,"marketCap":24830968078.3},{"date":"2024-02-09","current":4.838949,"twenty":3.892187,"median":9.837742,"eighty":12.805782,"marketCap":24362672332.27},{"date":"2024-02-16","current":4.745892,"twenty":3.892187,"median":9.837742,"eighty":12.805782,"marketCap":24147298816.1},{"date":"2024-02-23","current":4.838949,"twenty":3.892187,"median":9.834565,"eighty":12.805782,"marketCap":24431341401.84},{"date":"2024-03-01","current":4.939525,"twenty":3.893123,"median":9.737218,"eighty":12.803786,"marketCap":23952488130.27},{"date":"2024-03-08","current":4.508126,"twenty":3.893123,"median":9.70238,"eighty":12.803786,"marketCap":21947666113.83},{"date":"2024-03-15","current":4.572814,"twenty":3.893123,"median":9.667099,"eighty":12.803786,"marketCap":22370689783.86},{"date":"2024-03-22","current":4.583599,"twenty":3.893123,"median":9.548009,"eighty":12.778323,"marketCap":22474207427.59},{"date":"2024-03-28","current":4.475749,"twenty":3.893123,"median":9.466237,"eighty":12.778323,"marketCap":22089724123.39},{"date":"2024-04-05","current":5.004211,"twenty":3.892187,"median":9.402489,"eighty":12.787678,"marketCap":25269737391.93},{"date":"2024-04-12","current":4.874792,"twenty":3.892187,"median":9.295772,"eighty":12.787678,"marketCap":24296961694.18},{"date":"2024-04-19","current":4.799298,"twenty":3.892187,"median":9.274753,"eighty":12.787678,"marketCap":23301659582.09},{"date":"2024-04-26","current":4.971857,"twenty":3.893123,"median":9.175126,"eighty":12.778323,"marketCap":23960050881.17},{"date":"2024-05-03","current":4.864007,"twenty":3.893123,"median":8.95412,"eighty":12.778323,"marketCap":23752567318.04},{"date":"2024-05-10","current":5.383345,"twenty":3.893123,"median":8.867182,"eighty":12.778323,"marketCap":24064602087.79},{"date":"2024-05-17","current":5.430568,"twenty":3.893123,"median":8.795251,"eighty":12.778323,"marketCap":24652224339.04},{"date":"2024-05-24","current":5.418762,"twenty":3.893123,"median":8.740075,"eighty":12.778323,"marketCap":24601197777.08},{"date":"2024-05-31","current":5.548903,"twenty":3.893123,"median":8.682856,"eighty":12.778323,"marketCap":24948806455.5},{"date":"2024-06-07","current":5.584322,"twenty":3.893123,"median":8.59294,"eighty":12.778323,"marketCap":24693614094.28},{"date":"2024-06-14","current":5.678771,"twenty":3.892187,"median":8.439501,"eighty":12.787678,"marketCap":23998459101.92},{"date":"2024-06-21","current":5.501679,"twenty":3.892187,"median":8.381434,"eighty":12.789302,"marketCap":22878611698.83},{"date":"2024-06-28","current":5.489873,"twenty":3.892187,"median":8.310231,"eighty":12.794176,"marketCap":22954501069.55},{"date":"2024-07-05","current":5.383617,"twenty":3.892187,"median":8.217895,"eighty":12.794176,"marketCap":22901200413.63},{"date":"2024-07-12","current":5.289168,"twenty":3.892187,"median":8.13183,"eighty":12.794176,"marketCap":23204604596.91},{"date":"2024-07-15","current":5.171106,"twenty":3.892187,"median":8.107092,"eighty":12.794176,"marketCap":22824658784.59},{"date":"2024-08-02","current":5.005819,"twenty":3.876246,"median":7.931653,"eighty":12.819755,"marketCap":21485677284.4},{"date":"2024-08-09","current":4.923176,"twenty":3.876246,"median":7.848551,"eighty":12.819755,"marketCap":20886419400.33},{"date":"2024-08-16","current":5.133096,"twenty":3.876246,"median":7.728514,"eighty":12.819755,"marketCap":21386096998.62},{"date":"2024-08-23","current":5.009826,"twenty":3.876246,"median":7.673113,"eighty":12.819755,"marketCap":20566937957.91},{"date":"2024-08-30","current":5.034444,"twenty":3.876246,"median":7.608478,"eighty":12.819755,"marketCap":20378972525.7},{"date":"2024-09-06","current":4.739024,"twenty":3.876246,"median":7.506908,"eighty":12.819755,"marketCap":18940304213.61},{"date":"2024-09-13","current":4.751333,"twenty":3.876246,"median":7.359171,"eighty":12.819755,"marketCap":18705266064.42},{"date":"2024-09-20","current":4.689788,"twenty":3.876246,"median":7.2022,"eighty":12.819755,"marketCap":18729179929.81},{"date":"2024-09-27","current":4.677478,"twenty":3.876246,"median":7.088216,"eighty":12.819755,"marketCap":18693431578.81},{"date":"2024-10-04","current":4.689788,"twenty":3.876246,"median":7.005747,"eighty":12.819755,"marketCap":18661799148.11},{"date":"2024-10-11","current":4.542078,"twenty":3.876246,"median":6.779635,"eighty":12.819755,"marketCap":17972116015.88},{"date":"2024-10-18","current":4.283586,"twenty":3.876246,"median":6.671286,"eighty":12.819755,"marketCap":16817039340.09},{"date":"2024-10-25","current":4.258967,"twenty":3.876246,"median":6.623283,"eighty":12.819755,"marketCap":16507746997.84},{"date":"2024-10-31","current":4.234349,"twenty":3.876246,"median":6.412714,"eighty":12.819755,"marketCap":16032080809.48},{"date":"2024-11-08","current":4.086639,"twenty":3.871856,"median":6.252461,"eighty":12.821752,"marketCap":15687984275.04},{"date":"2024-11-15","current":4.646307,"twenty":3.871856,"median":6.207587,"eighty":12.821752,"marketCap":15845911157.34},{"date":"2024-11-22","current":4.84832,"twenty":3.871856,"median":6.102881,"eighty":12.821752,"marketCap":16898815061.19},{"date":"2024-11-29","current":4.794465,"twenty":3.871856,"median":5.9533,"eighty":12.821752,"marketCap":16560180234.91},{"date":"2024-12-06","current":4.76753,"twenty":3.871856,"median":5.863552,"eighty":12.821752,"marketCap":16531483452.13},{"date":"2024-12-13","current":4.888738,"twenty":3.871856,"median":5.80372,"eighty":12.821752,"marketCap":17216536903.6},{"date":"2024-12-20","current":4.525113,"twenty":3.871856,"median":5.699013,"eighty":12.821752,"marketCap":15739882212.82},{"date":"2024-12-27","current":4.471243,"twenty":3.871856,"median":5.666965,"eighty":12.821752,"marketCap":15580193842.54},{"date":"2025-01-03","current":4.834868,"twenty":3.871856,"median":5.596128,"eighty":12.821752,"marketCap":16773742492.85},{"date":"2025-01-10","current":4.888738,"twenty":3.867466,"median":5.572516,"eighty":12.823748,"marketCap":17240401252.68},{"date":"2025-01-17","current":5.036882,"twenty":3.867466,"median":5.525012,"eighty":12.823748,"marketCap":17692127998.87},{"date":"2025-01-24","current":4.780998,"twenty":3.867466,"median":5.495776,"eighty":12.823748,"marketCap":17203435182.51},{"date":"2025-01-31","current":5.454377,"twenty":3.867466,"median":5.476216,"eighty":12.823748,"marketCap":19996471191.52},{"date":"2025-02-07","current":5.387039,"twenty":3.867466,"median":5.430705,"eighty":12.823748,"marketCap":19814319642.43},{"date":"2025-02-14","current":5.642924,"twenty":3.867466,"median":5.419036,"eighty":12.823748,"marketCap":20806134000.52},{"date":"2025-02-21","current":6.020017,"twenty":3.867466,"median":5.419036,"eighty":12.823748,"marketCap":22526244057.4},{"date":"2025-02-28","current":5.521715,"twenty":3.867466,"median":5.419036,"eighty":12.823748,"marketCap":20445151021.05},{"date":"2025-03-07","current":5.506086,"twenty":3.863076,"median":5.395151,"eighty":12.825744,"marketCap":20009097615.46},{"date":"2025-03-14","current":5.533616,"twenty":3.863076,"median":5.395151,"eighty":12.825744,"marketCap":20124812820.07},{"date":"2025-03-21","current":5.781504,"twenty":3.863076,"median":5.430568,"eighty":12.825744,"marketCap":20608888189.85},{"date":"2025-03-28","current":5.987986,"twenty":3.863076,"median":5.451025,"eighty":12.825744,"marketCap":21549111072.47},{"date":"2025-04-04","current":5.506194,"twenty":3.863076,"median":5.451025,"eighty":12.825744,"marketCap":19860259232.96},{"date":"2025-04-11","current":4.914279,"twenty":3.867466,"median":5.419036,"eighty":12.823748,"marketCap":16779063126.51},{"date":"2025-04-17","current":5.24465,"twenty":3.867466,"median":5.387039,"eighty":12.823748,"marketCap":18166222924.7},{"date":"2025-04-25","current":5.065699,"twenty":3.863076,"median":5.359734,"eighty":12.825744,"marketCap":17692043924.42},{"date":"2025-05-02","current":4.749093,"twenty":3.863076,"median":5.341009,"eighty":12.825744,"marketCap":16641162417.65},{"date":"2025-05-09","current":5.033609,"twenty":3.863076,"median":5.313373,"eighty":12.825744,"marketCap":16592927164.26},{"date":"2025-05-16","current":5.26773,"twenty":3.863076,"median":5.289168,"eighty":12.825744,"marketCap":17573740428.84},{"date":"2025-05-23","current":5.2092,"twenty":3.863076,"median":5.283553,"eighty":12.825744,"marketCap":17527892838.75},{"date":"2025-05-30","current":5.252965,"twenty":3.863076,"median":5.26773,"eighty":12.825744,"marketCap":17978725723.75},{"date":"2025-06-06","current":5.209068,"twenty":3.863076,"median":5.252534,"eighty":12.825744,"marketCap":17843264146.13},{"date":"2025-06-13","current":5.633402,"twenty":3.863076,"median":5.252534,"eighty":12.825744,"marketCap":18968446636.05},{"date":"2025-06-20","current":5.838253,"twenty":3.860032,"median":5.248592,"eighty":12.825744,"marketCap":20100420472.58},{"date":"2025-06-27","current":5.501712,"twenty":3.860032,"median":5.248592,"eighty":12.825744,"marketCap":19109388152.88},{"date":"2025-07-03","current":5.428551,"twenty":3.860032,"median":5.248592,"eighty":12.825744,"marketCap":19182000062.86},{"date":"2025-07-11","current":5.296861,"twenty":3.860032,"median":5.248592,"eighty":12.825744,"marketCap":18526566439.86},{"date":"2025-07-18","current":5.238332,"twenty":3.860032,"median":5.24465,"eighty":12.825744,"marketCap":18338287610.28},{"date":"2025-07-25","current":5.135907,"twenty":3.860032,"median":5.240329,"eighty":12.825744,"marketCap":17804924788.04},{"date":"2025-07-31","current":5.194436,"twenty":3.860032,"median":5.230878,"eighty":12.825744,"marketCap":17474053793.7}],"updateTime":1754057614559}}}